Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

NVP-ADW742

Cat. No.: IBDI-434481

NVP-ADW742 (ADW742) is an orally active, selective IGF-1R tyrosine kinase inhibitor with an IC50 of 0.17 μM. NVP-ADW742 inhibits insulin receptor (InsR) with an IC50 of 2.8 μM. NVP-ADW742 induces pleiotropic antiproliferative/proapoptotic biologic sequelae in tumor cells.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target IGF-1R | Insulin Receptor | Apoptosis
Molecular Weight 453.58
Appearance Solid
Synonyms ADW742, GSK 552602A, ADW
SMILES NC1=C2C(N(C=C2C3=CC=CC(OCC4=CC=CC=C4)=C3)[[email protected]]5C[[email protected]@H](C5)CN6CCCC6)=NC=N1
Purity 99.54%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Powder: -20°C/3 years; 4°C/2 years
In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.